Sep 2024 – New PhD graduate Dr. Jean-Pierre Amoakon reports that Defective CFTR modulates mechanosensitive channels TRPV4 and PIEZO1 and drives endothelial barrier failure.

Sep 4, 2024 – In the student-organized seminar series, David Dadosky (Wohleb lab) presented "Examining the role of glucocorticoid signaling in the behavioral and synaptic effects of tryptamines".

Sep 4, 2024 –  In the student-organized seminar series, Luis Tron Esqueda (Fan lab) described "The role endothelial TFEB plays in the blood-brain barrier and Alzheimer's disease".

Sep 1, 2024 – Chair Dr. Herman announced that our faculty voted to become the Department of Pharmacology, Physiology, and Neurobiology. This name reflects the breadth of our faculty research and educational programs.

Sep 2024 – With her co-authors, she reported that NORE1A loss promotes MASLD/MASH, a finding relevant to liver disease.

Sep 2024 – A collaborative group described The influence of paraventricular nucleus of the hypothalamus soluble guanylate cyclase on autonomic and neuroendocrine responses to acute restraint stress in rats.

Sep 21, 2024 – At the Ohio Physiological Society meeting, Noble (Chella Krishnan lab) earned a top award for his talk "Functional compartmentalization of hepatic mitochondrial subpopulations during MASH progression".

Sep 2024 – The team's report, Association of same-day urinary phenol levels and cardiac electrical alterations: analysis of the Fernald Community Cohort, received national attention.